MedKoo Cat#: 574477 | Name: Meclocycline sulfosalicylate salt
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Meclocycline sulfosalicylate salt is a tetracycline antibiotic that is topically used for skin infections and irritations.

Chemical Structure

Meclocycline sulfosalicylate salt
Meclocycline sulfosalicylate salt
CAS#73816-42-9

Theoretical Analysis

MedKoo Cat#: 574477

Name: Meclocycline sulfosalicylate salt

CAS#: 73816-42-9

Chemical Formula: C29H27ClN2O14S

Exact Mass: 694.0872

Molecular Weight: 695.05

Elemental Analysis: C, 50.11; H, 3.92; Cl, 5.10; N, 4.03; O, 32.23; S, 4.61

Price and Availability

Size Price Availability Quantity
5mg USD 290.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
Synonym
Meclocycline sulfosalicylate salt; Meclan; Mecloderm; Meclutin; Traumatociclina
IUPAC/Chemical Name
2-Hydroxy-5-sulfo-benzoic Acid (4S,4aR,5S,5aR,12aS)-7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide
InChi Key
FYSVKUUNXYGFLA-CCHMMTNSSA-N
InChi Code
InChI=1S/C22H21ClN2O8.C7H6O6S/c1-6-9-7(23)4-5-8(26)11(9)16(27)12-10(6)17(28)14-15(25(2)3)18(29)13(21(24)32)20(31)22(14,33)19(12)30;8-6-2-1-4(14(11,12)13)3-5(6)7(9)10/h4-5,10,14-15,17,26,28-30,33H,1H2,2-3H3,(H2,24,32);1-3,8H,(H,9,10)(H,11,12,13)/t10-,14-,15+,17+,22+;/m1./s1
SMILES Code
O=C(O)C1=CC(S(=O)(O)=O)=CC=C1O.O=C(C(C2=O)=C(O)[C@@H](N(C)C)[C@]3([H])[C@@H](O)[C@]4([H])C(C5=C(C(C4=C(O)[C@@]32O)=O)C(O)=CC=C5Cl)=C)N
Appearance
Off-White to Beige Solid
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Meclocycline Sulfosalicylate Salt is a tetracycline antibiotic with broad-spectrum antibacterial activities, preventing skin bacterial infections such as acne vulgaris.
In vitro activity:
TBD
In vivo activity:
In a screen of 2000 compounds, six were found to produce significant protection of C. elegans from delayed death. Four of the compounds were tested in an ex vivo mouse heart ischemia/reperfusion model and two, meclocycline and 3-amino-1,2,4-triazole, significantly reduced infarction size. Reference: PLoS One. 2017 Apr 20;12(4):e0176061. https://pubmed.ncbi.nlm.nih.gov/28426808/
Solvent mg/mL mM
Solubility
DMSO 250.0 359.69
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 695.05 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
Sun CL, Zhang H, Liu M, Wang W, Crowder CM. A screen for protective drugs against delayed hypoxic injury. PLoS One. 2017 Apr 20;12(4):e0176061. doi: 10.1371/journal.pone.0176061. PMID: 28426808; PMCID: PMC5398677.
In vitro protocol:
TBD
In vivo protocol:
Sun CL, Zhang H, Liu M, Wang W, Crowder CM. A screen for protective drugs against delayed hypoxic injury. PLoS One. 2017 Apr 20;12(4):e0176061. doi: 10.1371/journal.pone.0176061. PMID: 28426808; PMCID: PMC5398677.